Tag: patent litigation

How Paragraph IV Patent Challenges Speed Up Generic Drug Entry

Paragraph IV under the Hatch-Waxman Act lets generic drug makers challenge weak patents to speed up affordable drug access. Learn how it works, why it matters, and how it saves billions in healthcare costs.